Virtuos, the studio behind Oblivion Remastered, is reportedly laying off staff
The brunt of the layoffs are happening to Virtuos employees in China, where Andres reports that around 200 positions are being eliminated. Virtuos' teams in France, who were primarily responsible for the surprise release of Oblivion Remastered back in April, are also expected to be impacted.
Besides reviving Bethesda classics, Virtuos has contributed work to the upcoming Metal Gear Solid Delta: Snake Eater and several ongoing live service games, like Dune: Awakening and Sea of Thieves . Nothing about the company's output or the critical reception of its games would suggest it needs to conduct layoffs, but that reflects the current precarious state of the games industry. Even having theoretically steady work doing post-release support and game remasters isn't enough.
Virtuos' layoffs follows the sweeping cuts Microsoft made to its Xbox division in early July. Microsoft reportedly cancelled games, like Rare's long-in-development Everwild , and shutdown whole studios, like The Initiative. Romero Games, which had an unannounced funding deal with Microsoft, was also forced to cancel its current project, though it hopes to find a new publishing partner.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
8 minutes ago
- Associated Press
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN ) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent application (Publication No. WO 2025/129197) titled, 'Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models.' This patent covers technology developed by that leverages machine learning algorithms, powered by Microsoft (Nasdaq: MSFT ) and Databricks intended to rapidly and accurately identify peptides with strong immune system interactions. Identifying these peptides is critical in developing targeted therapies for a variety of diseases, including cancers and infectious diseases. Traditional methods for identifying immunologically active peptides often face significant limitations, such as overlooking critical human genetic diversity factors like age, sex, race, and ethnicity. proprietary approach may overcome these challenges by: 'I'm pleased with continued progress in strategically harnessing artificial intelligence in support of our cell therapy development,' said Dr. Ryan Saadi, Founder and CEO of Tevogen. 'Leveraging AI to accelerate discovery, shorten development timelines, and reduce costs is essential to our mission of delivering commercially attractive, economically viable, and cost-effective personalized T cell therapies.' Forward Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts Tevogen Bio Communications T: 1 877 TEVOGEN, Ext 701 [email protected]
CBS News
8 minutes ago
- CBS News
Former Giants managing general partner, longtime Microsoft attorney Bill Neukom dies at 83
Former San Francisco Giants managing general partner Bill Neukom, a bow-tie loving, longtime Microsoft attorney who was at the helm when the team won its first World Series title in 2010, has died. He was 83. The team announced Neukom's death Thursday. No additional information was provided. Neukom retired from his role following the 2011 season and after the Giants captured the 2010 World Series for their first of three every-other-year titles that included championships in 2012 and 2014. The 2010 victory marked the first for the team since moving West in 1958. "Bill will always hold a special place in our hearts and in the history of this franchise," Giants CEO Larry Baer said in a statement. "He was instrumental in helping this organization and its players bring the first World Series Championship to San Francisco in 2010. Bill will always be remembered for not only his leadership of this storied organization but also his colorful bow ties and the fact he'd bring a glove to the ballpark to try and catch foul balls. He was a true gentleman, a dedicated fan and a friend to so many." An avid runner who completed more than a half-dozen marathons, Neukom first joined the ownership group in 1995 and became a general partner in 2003. When Peter Magowan retired after the 2008 season, Neukom became managing general partner. He developed a catchphrase called "The Giants Way" of playing baseball. "My idea is that we adhere to it at the minor-league level and all the way up," Neukom said when introduced in October 2008. "It's how you play the game, conditioning, fundamentals, a rigorous spring training regimen, everything. We want the best talent, the best teachers, the best leaders, the best trainers, and we want to have better communication on what we want and how we want it done." After retiring, Neukom remained involved with the Giants as chairman emeritus. He grew up in nearby San Mateo rooting for the Giants and with then-San Francisco Seals owner Charlie Graham as a neighbor. Neukom also loved riding horses and stayed active despite undergoing hip replacement surgery during his Giants tenure. Serving as top counsel for Microsoft billionaire Bill Gates, Neukom was the company's lead lawyer for nearly 25 years. His Microsoft stake was worth an estimated $107 million when he left in 2001. He was a partner in the Seattle office of the law firm Kirkpatrick & Lockhart Preston Gates Ellis. He also was a past president of the American Bar Association, serving in 2007-08. Neukom also founded the World Justice Project in 2006, a multinational, multidisciplinary initiative to strengthen the rule of law worldwide.
Yahoo
11 minutes ago
- Yahoo
Xbox Is Done Selling Movies And TV Shows
12 years after Xbox introduced the Xbox One as a console that would be your entertainment media hub, Xbox is no longer selling TV shows or movies. The news came with little fanfare or notice, though some people who regularly check Xbox's movie and TV section saw a bunch of movies about the end of the world in the featured section right before it all shut down. On July 18, Xbox posted an FAQ quietly confirming that it was done selling movies and TV episodes on its digital storefront, available on PC and console. 'Microsoft has stopped selling new movie and TV content,' said Xbox bluntly in the new FAQ. Microsoft says that anyone who has already bought a movie or TV show through the Xbox store will still have access and be able to watch purchased content on their Xbox consoles or PC. The company also confirmed that it will continue to support MoviesAnywhere in the United States, so any movies you own via Xbox should continue to be available via any platform that supports the movie sharing service. While in 2025 it isn't shocking that Xbox has backed out of selling movies and TV shows, as most people stream stuff or use more popular apps to buy new movies, it is still wild to think about how not that long ago, Xbox was super committed to turning its console into an entertainment hub. Infamously, when Xbox showed off the Xbox One in 2012 for the first time, it spent a good portion of the event talking about TV and movies. Now, that's all gone. End of an era. Some people saw this coming a few days ago when they noticed a strange collection of movies was in the featured section of the Xbox store. This Is the End End of Days Marvel Studios' Avengers: Endgame Marked For Death The Last Stand The World's End Seeking a Friend for the End of the World I Am Legend 'It certainly looks like this is the end,' posted one user earlier this week after seeing the featured movies. 'Hopefully, we'll at least have access to our digital purchases for a long time.' . For the latest news, Facebook, Twitter and Instagram. Solve the daily Crossword
